STAAR Surgical Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 26, 2025	Dec '24 Dec 27, 2024	Dec '23 Dec 29, 2023	Dec '22 Dec 30, 2022	Dec '21 Dec 31, 2021	Jan '21 Jan 1, 2021
Revenue	230.59	313.9	322.42	284.39	230.47	163.46
Revenue Growth (YoY)	-32.42%	-2.64%	13.37%	23.39%	41.00%	8.84%
Cost of Revenue	60.26	74.32	69.76	61.01	51.84	45.1
Gross Profit	170.33	239.58	252.65	223.38	178.64	118.36
Selling, General & Admin	183.77	197.96	178.54	143.1	111.54	79.75
Research & Development	49.24	53.97	44.4	35.98	33.86	31.92
Operating Expenses	233.01	251.93	222.94	179.08	145.4	111.66
Operating Income	-62.68	-12.35	29.71	44.3	33.24	6.7
Interest Expense	-	-	-	-	-0.04	-
Interest & Investment Income	5.08	5.91	6.99	2.45	-	0.24
Currency Exchange Gain (Loss)	-1.12	-3.68	-1.91	-1.71	-2.96	0.86
Other Non Operating Income (Expenses)	0.65	1.06	0.3	0.81	1.07	0.47
EBT Excluding Unusual Items	-58.08	-9.05	35.09	45.85	31.3	8.27
Merger & Restructuring Charges	-19.27	-	-	-	-	-
Other Unusual Items	-	-	-1.39	-0.3	-	-
Pretax Income	-91.95	-9.05	33.7	45.55	31.3	8.27
Income Tax Expense	4.42	11.16	12.35	5.89	3.79	2.35
Net Income	-96.37	-20.21	21.35	39.67	27.51	5.91
Net Income to Common	-96.37	-20.21	21.35	39.67	27.51	5.91
Net Income Growth	-	-	-46.18%	44.18%	365.26%	-57.91%
Shares Outstanding (Basic)	49	49	49	48	47	46
Shares Outstanding (Diluted)	49	49	49	49	49	48
Shares Change (YoY)	-0.15%	-0.61%	0.10%	-0.15%	3.13%	2.26%
EPS (Basic)	-1.95	-0.41	0.44	0.83	0.58	0.13
EPS (Diluted)	-1.95	-0.41	0.43	0.80	0.56	0.12
EPS Growth	-	-	-46.25%	42.86%	366.67%	-60.00%
Free Cash Flow	-39.54	-7.67	-3.59	17.61	30.32	12.55
Free Cash Flow Per Share	-0.80	-0.16	-0.07	0.36	0.61	0.26
Gross Margin	73.87%	76.32%	78.36%	78.55%	77.51%	72.41%
Operating Margin	-27.18%	-3.93%	9.21%	15.58%	14.42%	4.10%
Profit Margin	-41.79%	-6.44%	6.62%	13.95%	11.94%	3.62%
Free Cash Flow Margin	-17.15%	-2.44%	-1.11%	6.19%	13.15%	7.68%
EBITDA	-53.99	-5.46	34.83	48.81	36.88	9.79
EBITDA Margin	-23.41%	-1.74%	10.80%	17.16%	16.00%	5.99%
D&A For EBITDA	8.69	6.89	5.12	4.51	3.64	3.1
EBIT	-62.68	-12.35	29.71	44.3	33.24	6.7
EBIT Margin	-27.18%	-3.93%	9.21%	15.58%	14.42%	4.10%
Effective Tax Rate	-	-	36.65%	12.92%	12.12%	28.48%
Advertising Expenses	-	34.08	46.68	37.92	21.99	11.08

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q